SS
Stacey Seltzer
Board Member at Reneo Pharmaceuticals
New York, New York
Overview
Stacey Seltzer is a Partner at Gurnet Point Capital in New York, with a background that includes serving on the board of Reneo Pharmaceuticals and Aimmune Therapeutics. She has made significant investments in companies like Aimmune Therapeutics and Agile Therapeutics, demonstrating a strong track record in the biotech and pharmaceutical sectors.
Work Experience
Managing Partner and Founder
2024 - Current
Board Member
2020
Partner
2022 - 2024
Gurnet Point Capital is a private equity firm that invests in de-risked life sciences companies
Partner
2014 - 2022
Principal
2008 - 2014
Board Member
2015 - 2020
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Raised $540,000,002.00 from Nestlé Health Science, Nestlé Health Science and Nestlé Health Science.
Board Member
2011 - 2017
Associate Director, US Marketing
2007 - 2008
Senior Manager, Global Licensing
2005 - 2007
Management Associate
2004 - 2005
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Raised $5,586,000.00 from Private Capital Advisors.
Director, Business Development
2001 - 2002
Business Analyst
1998 - 2000
Education
MBA
2002 - 2004
M.S. / B.S.
1994 - 1998